by Gabi Schaller | May 17, 2023 | News
May 17, 2023 – VIENNA, AUSTRIA: SynBioBeta – the largest synthetic biology industry conference – is back in 2023 and Ribbon Biolabs is very excited to be part of it. For the first time, Ribbon Biolabs will be present with a company booth and offer a...
by Gabi Schaller | May 10, 2023 | News
May 10, 2023 – VIENNA, AUSTRIA: Ribbon Biolabs, the DNA synthesis company, today announced the appointment of Jodi Barrientos as Chief Business Officer. With over 17 years of experience in industry-leading life science and diagnostics companies, Jodi Barrientos...
by Gabi Schaller | Dec 20, 2022 | News
December 20, 2022 – VIENNA, AUSTRIA: Ribbon Biolabs, the DNA synthesis company, today announced the successful implementation of their innovative InfiniSynth™ platform for the automated assembly of sequence-agnostic and long DNA. Ribbon Biolabs achieved this...
by Gabi Schaller | Aug 16, 2022 | Allgemein, News
We are thrilled to be shortlisted as one of 25 winners of the Falling Walls Venture 2022! Falling Walls Venture is a global platform for the most promising science start-ups who have successfully turned science into business, proving how entrepreneurial solutions can...
by Gabi Schaller | Jul 19, 2022 | Allgemein, News
We are very proud to announce the issuance of our first U.S. patent (US 11352619 B2) covering our novel method for synthesizing double stranded DNA using a diverse library of oligonucleotides. The patent enables us to proprietarily exploit our differentiating...
by Gabi Schaller | Jun 30, 2022 | Allgemein, News
Ribbon Biolabs is very honoured to be one of 15 innovative Start-ups awarded as ‘Born Global Champions’. The award is presented annually by the Austrian Economic Chamber to young companies that have succeeded in positioning innovative products and services...
